相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma
Jennifer A. Lenz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
Safety evaluation of the canine osteosarcoma vaccine, liveListeriavector
Margaret L. Musser et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2021)
A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia
Massimo Martino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate
Matthew J. Cascio et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2021)
Type I and II Interferons in the Anti-Tumor Immune Response
Sarah E. Fenton et al.
CANCERS (2021)
PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma
Naoya Maekawa et al.
NPJ PRECISION ONCOLOGY (2021)
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
Amy K. LeBlanc et al.
CLINICAL CANCER RESEARCH (2021)
Intratumoral T-Lymphocyte Subsets in Canine Oral Melanoma and Their Association With Clinical and Histopathological Parameters
Cassia C. Yasumaru et al.
VETERINARY PATHOLOGY (2021)
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Tengku Ibrahim Maulana et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
PD-1, PD-L1, and PD-L2 Gene Expression and Tumor Infiltrating Lymphocytes in Canine Melanoma
Valentina B. Stevenson et al.
VETERINARY PATHOLOGY (2021)
Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds
Burair A. Alsaihati et al.
NATURE COMMUNICATIONS (2021)
Immunotherapy for Dogs: Still Running Behind Humans
Hans Klingemann
FRONTIERS IN IMMUNOLOGY (2021)
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
Aaron C. Tan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
William C. Kisseberth et al.
FRONTIERS IN VETERINARY SCIENCE (2021)
Canine Transforming Growth Factor-β Receptor 2-Ig: A Potential Candidate Biologic for Melanoma Treatment That Reverses Transforming Growth Factor-β1 Immunosuppression
Hiroto Takeuchi et al.
FRONTIERS IN VETERINARY SCIENCE (2021)
Transcriptome analysis of dog oral melanoma and its oncogenic analogy with human melanoma
Md. Mahfuzur Rahman et al.
ONCOLOGY REPORTS (2020)
Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma
M. Kazim Panjwani et al.
ONCOIMMUNOLOGY (2020)
Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy
Pauline Thumser-Henner et al.
BMC VETERINARY RESEARCH (2020)
Tumour-infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3+ and CD20+ lymphocytic populations
Ilaria Porcellato et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2020)
Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression
Timothy M. Fan et al.
FRONTIERS IN ONCOLOGY (2020)
A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors
Agata Mlynska et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2020)
Cancer immunotherapy: Pros, cons and beyond
Shuzhen Tan et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
A Role for Dogs in Advancing Cancer Immunotherapy Research
Steven Dow
FRONTIERS IN IMMUNOLOGY (2020)
The Expression of Selected Factors Related to T Lymphocyte Activity in Canine Mammary Tumors
Joanna K. Bujak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models
Takahiro Yamazaki et al.
ONCOIMMUNOLOGY (2020)
Multimodality treatment including ONCEPT for canine oral melanoma: A retrospective analysis of 131 dogs
Michelle Turek et al.
VETERINARY RADIOLOGY & ULTRASOUND (2020)
Mouse Tumor Models for Advanced Cancer Immunotherapy
Dania S. Chulpanova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Autologous cancer cell vaccination, adoptiveT-cell transfer, and interleukin-2 administration results in long-term survival for companion dogs with osteosarcoma
Brian K. Flesner et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2020)
Development of canine PD-1/PD-L1 specific monoclonal antibodies and amplification of canine T cell function
Jin Wook Choi et al.
PLOS ONE (2020)
Optimization of canine CD20 chimeric antigen receptor T cell manufacturing and in vitro cytotoxic activity against B-cell lymphoma
Osamu Sakai et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2020)
Chemokine gene expression influences metastasis and survival time of female dogs with mammary carcinoma
Harsha Ariyarathna et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2020)
Localized Interleukin-12 for Cancer Immunotherapy
Khue G. Nguyen et al.
FRONTIERS IN IMMUNOLOGY (2020)
Humanized Rodent Models for Cancer Research
Huimin Tian et al.
FRONTIERS IN ONCOLOGY (2020)
Increased programmed death ligand (PD-L1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4) expression is associated with metastasis and poor prognosis in malignant canine mammary gland tumours
Harsha Ariyarathna et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2020)
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
Ombretta Melaiu et al.
NATURE COMMUNICATIONS (2020)
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (vol 8, e000337, 2020)
Lorenzo Galluzzi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs
Masaya Igase et al.
SCIENTIFIC REPORTS (2020)
A Preliminary Study of the Cross-Reactivity of Canine MAGE-A with Hominid Monoclonal Antibody 6C1 in Canine Mammary Gland Tumors: An Attractive Target for Cancer Diagnostic, Prognostic and Immunotherapeutic Development in Dogs
Wanwisa Srisawat et al.
VETERINARY SCIENCES (2020)
Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials
Bin Zhao et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
The T-cell-inflamed tumor microenvironment as a paradigm for immunotherapy drug development
Daniel J. Olson et al.
IMMUNOTHERAPY (2019)
Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma
Michael R. Olin et al.
CANCERS (2019)
Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
Shweta Joshi et al.
JOURNAL OF ONCOLOGY (2019)
Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma
Sita S. Withers et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2019)
Complementing the Cancer-Immunity Cycle
Ruben Pio et al.
FRONTIERS IN IMMUNOLOGY (2019)
Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment
Yoshiro Itatani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tumor-infiltrating CD4+ and CD8+ lymphocytes and macrophages are associated with prognostic factors in triple-negative canine mammary complex type carcinoma
Mayara Simao Franzoni et al.
RESEARCH IN VETERINARY SCIENCE (2019)
Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy
Alicia A. Gingrich et al.
JOURNAL OF CLINICAL MEDICINE (2019)
A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
Linh Khanh Huynh et al.
BIOMOLECULES (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma
Kim Wong et al.
NATURE COMMUNICATIONS (2019)
Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
Karim Vermaelen
FRONTIERS IN IMMUNOLOGY (2019)
Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies
Timothy M. Fan et al.
FRONTIERS IN ONCOLOGY (2019)
Array Comparative Genomic Hybridization Analysis Reveals Significantly Enriched Pathways in Canine Oral Melanoma
Ginevra Brocca et al.
FRONTIERS IN ONCOLOGY (2019)
STING activation in cancer immunotherapy
Ting Su et al.
THERANOSTICS (2019)
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy
Junjie Wu et al.
CANCER LETTERS (2018)
MAGE-A antigens as targets for cancer immunotherapy
Erik Schooten et al.
CANCER TREATMENT REVIEWS (2018)
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2018)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Canine sarcomas as a surrogate for the human disease
Daniel L. Gustafson et al.
PHARMACOLOGY & THERAPEUTICS (2018)
The inducers of immunogenic cell death for tumor immunotherapy
Xiuying Li
TUMORI JOURNAL (2018)
Checkpoint molecule expression by B and T cell lymphomas in dogs
G. Hartley et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
Mieke Metzemaekers et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immunotherapy for Dogs: Running Behind Humans
Hans Klingemann
FRONTIERS IN IMMUNOLOGY (2018)
TGF-β in T Cell Biology: Implications for Cancer Immunotherapy
Amina Dahmani et al.
CANCERS (2018)
The inducers of immunogenic cell death for tumor immunotherapy
Xiuying Li
TUMORI JOURNAL (2018)
Topography of cancer-associated immune cells in human solid tumors
Jakob Nikolas Kather et al.
ELIFE (2018)
Of Mice, Dogs, Pigs, and Men: Choosing the Appropriate Model for Immuno-Oncology Research
Nana H. Overgaard et al.
ILAR JOURNAL (2018)
Monoclonal antibodies in cancer immunotherapy
Ilgin Kimiz-Gebologlu et al.
MOLECULAR BIOLOGY REPORTS (2018)
Immune regulation of canine tumour and macrophage PD-L1 expression
G. Hartley et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2017)
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination
L. A. Piras et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
T Lymphocytes in Histiocytic Sarcomas of Flat-Coated Retriever Dogs
A. Marcinowska et al.
VETERINARY PATHOLOGY (2017)
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications
Martina Musella et al.
ONCOIMMUNOLOGY (2017)
Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial
Robert J. Canter et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma
Naoya Maekawa et al.
SCIENTIFIC REPORTS (2017)
Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics
Siobhan Simpson et al.
ACTA VETERINARIA SCANDINAVICA (2017)
MAGE-A Antigens and Cancer Immunotherapy
Paul Zajac et al.
FRONTIERS IN MEDICINE (2017)
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
J. M. Kim et al.
ANNALS OF ONCOLOGY (2016)
Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma
Nicola J. Mason et al.
CLINICAL CANCER RESEARCH (2016)
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Priti S. Hegde et al.
CLINICAL CANCER RESEARCH (2016)
Association of Canine Osteosarcoma and Monocyte Phenotype and Chemotactic Function
J. L. Tuohy et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2016)
A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma
Elisabetta Treggiari et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2016)
Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma
M. Kazim Panjwani et al.
MOLECULAR THERAPY (2016)
Cancer immunology and canine malignant melanoma: A comparative review
Matthew J. Atherton et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2016)
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
Francesco Passiglia et al.
ONCOTARGET (2016)
Dogs as a Model for Cancer
Heather L. Gardner et al.
ANNUAL REVIEW OF ANIMAL BIOSCIENCES, VOL 4 (2016)
A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs
Maria Isabel Carvalho et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Canine cancer immunotherapy studies: linking mouse and human
Jiwon S. Park et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma
Michihito Tagawa et al.
PLOS ONE (2016)
Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma
Naoya Maekawa et al.
PLOS ONE (2016)
Canine transmissible venereal tumour: a review
B. Ganguly et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
The Immunotherapy of Canine Osteosarcoma: A Historical and Systematic Review
K. L. Wycislo et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2015)
Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the Disease
Thomas Welte et al.
MEDIATORS OF INFLAMMATION (2015)
Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma
Melissa Paoloni et al.
PLOS ONE (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment
Thomas F. Gajewski
SEMINARS IN ONCOLOGY (2015)
Intratumoral CD3+T-Lymphocytes Immunoexpression and Its Association with c-Kit, Angiogenesis, and Overall Survival in Malignant Canine Mammary Tumors
Maria Isabel Carvalho et al.
ANALYTICAL CELLULAR PATHOLOGY (2015)
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
Stephan Herbertz et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
The Regulatory Role of Invariant NKT Cells in Tumor Immunity
Rosanna M. McEwen-Smith et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Corrigendum: “Combinatorial Strategies for the Induction of Immunogenic Cell Deathâ€
Lucillia Bezu et al.
Frontiers in Immunology (2015)
Combinatorial strategies for the induction of immunogenic cell death
Lucillia Bezu et al.
FRONTIERS IN IMMUNOLOGY (2015)
CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study
Benedikt Fritzsching et al.
ONCOIMMUNOLOGY (2015)
Immunology of naturally transmissible tumours
Hannah V. Siddle et al.
IMMUNOLOGY (2015)
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma
Carsten Linnemann et al.
NATURE MEDICINE (2015)
Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem
Yaritza Salas et al.
PLOS ONE (2015)
Morphology and immunophenotype of canine cutaneous histiocytic tumours with particular emphasis on diagnostic application
Katarzyna Pazdzior-Czapula et al.
VETERINARY RESEARCH COMMUNICATIONS (2015)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA
Federica Riccardo et al.
CLINICAL CANCER RESEARCH (2014)
High hydrostatic pressure induces immunogenic cell death in human tumor cells
Jitka Fucikova et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012)
Sarah E. Boston et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2014)
Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998-2011)
Joanne L. Tuohy et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2014)
Toward Immunotherapy With Redirected T Cells in a Large Animal Model: Ex Vivo Activation, Expansion, and Genetic Modification of Canine T Cells
Melinda Mata et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Comparison of Carboplatin and Doxorubicin-Based Chemotherapy Protocols in 470 Dogs after Amputation for Treatment of Appendicular Osteosarcoma
L. E. Selmic et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Expression of PD-L1 on Canine Tumor Cells and Enhancement of IFN-γ Production from Tumor-Infiltrating Cells by PD-L1 Blockade
Naoya Maekawa et al.
PLOS ONE (2014)
A Role for T-Lymphocytes in Human Breast Cancer and in Canine Mammary Tumors
Maria Isabel Carvalho et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp et al.
ONCOIMMUNOLOGY (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
The effect of interleukin-2 on canine peripheral nerve sheath tumours after marginal surgical excision: a double-blind randomized study
Annika N. Haagsman et al.
BMC VETERINARY RESEARCH (2013)
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
Thomas F. Gajewski et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Deciphering and Reversing Tumor Immune Suppression
Greg T. Motz et al.
IMMUNITY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression
Yong-Chen Lu et al.
JOURNAL OF IMMUNOLOGY (2013)
Treatment Efficacy and Immune Stimulation by AdCD40L Gene Therapy of Spontaneous Canine Malignant Melanoma
Sara Westberg et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma
J. M. Ottnod et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2013)
Species-specific properties and translational aspects of canine dendritic cells
V. Qeska et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2013)
Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway
Jiao Chen et al.
IMMUNOBIOLOGY (2012)
Correlation of Foxp3 positive regulatory T cells with prognostic factors in canine mammary carcinomas
J. H. Kim et al.
VETERINARY JOURNAL (2012)
The determinants of tumour immunogenicity
Thomas Blankenstein et al.
NATURE REVIEWS CANCER (2012)
Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor
Deborah A. Grosenbaugh et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2011)
Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior
Benoit Hedan et al.
BMC CANCER (2011)
Immunohistochemical Expression of E-cadherin Does Not Distinguish Canine Cutaneous Histiocytoma From Other Canine Round Cell Tumors
J. A. Ramos-Vara et al.
VETERINARY PATHOLOGY (2011)
Lymphocyte Infiltration, Expression of Interleukin (IL)-1, IL-6 and Expression of Mutated Breast Cancer Susceptibility Gene-1 Correlate with Malignancy of Canine Mammary Tumours
J. -H. Kim et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2010)
Molecular Analysis of Tumor-Promoting CD8+ T Cells in Two-Stage Cutaneous Chemical Carcinogenesis
Bernice Y. Kwong et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Association of Blood Monocyte and Lymphocyte Count and Disease-Free Interval in Dogs with Osteosarcoma
J. L. Sottnik et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2010)
Decreased Ratio of CD8+ T Cells to Regulatory T Cells Associated with Decreased Survival in Dogs with Osteosarcoma
B. J. Biller et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2010)
Mammary Tumor Development in Dogs Is Associated with BRCA1 and BRCA2
Patricio Rivera et al.
CANCER RESEARCH (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression
Ya-Wen Hsiao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
LAG-3 regulates CD8+T cell accumulation and effector function in murine self- and tumor-tolerance systems
Joseph F. Grosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Canine oral melanoma
Philip J. Bergman
CLINICAL TECHNIQUES IN SMALL ANIMAL PRACTICE (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Clonal origin and evolution of a transmissible cancer
Claudio Murgia et al.
CELL (2006)
Cortical allograft and endoprosthesis for limb-sparing surgery in dogs with distal radial osteosarcoma: A prospective clinical comparison of two different limb-sparing techniques
Julius M. Liptak et al.
VETERINARY SURGERY (2006)
The regression of a canine Langerhans cell tumour is associated with increased expression of IL-2, TNF-α, IFN-γ and iNOS mRNA
Ute Kaim et al.
IMMUNOLOGY (2006)
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma
AN Alexander et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma
BDX Lascelles et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases
S Dow et al.
HUMAN GENE THERAPY (2005)
Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-β1 and restores the lymphokine-activated killing activity
YW Hsiao et al.
JOURNAL OF IMMUNOLOGY (2004)
Canine transmissible venereal tumour: cytogenetic origin, unophenotype, and immunobiology. A review
S Mukaratirwa et al.
VETERINARY QUARTERLY (2003)
A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation
DR Proulx et al.
VETERINARY RADIOLOGY & ULTRASOUND (2003)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs
VK Affolter et al.
VETERINARY PATHOLOGY (2002)
Review of canine transmissible venereal sarcoma
U Das et al.
VETERINARY RESEARCH COMMUNICATIONS (2000)
分享论文
